Medication-Related Osteonecrosis of the Jaw: A Multidisciplinary Approach

Dr. Philip Kuruvilla

Dr. Deborah Saunders

Dr. David Yang

Dr. Maria Jiang

What is the Preferred Terminology and Definition for Osteonecrosis of the Jaw (Maxilla and Mandible) Associated with Pharmacologic Therapies in Oncology Patients?
What Outcome Measures Should be Utilized in Clinical Practice to Describe the Response of the MRONJ Lesion to Treatment?

Hidden

Organization

Name*

Email*

Postal Code*

Institution/Workplace

Password*

Under the guidance of Innovative Medicines Canada this webinar is for healthcare professionals only.

Hidden

Emails Validation

Hidden

Emails Error Message

This program has been made possible by support from Amgen Canada Inc.

The opinions expressed at this presentation are those of the speakers and do not reflect the view of Amgen Canada Inc.